Sign up for our free China-Africa Week in Review email newsletter
  • This field is for validation purposes and should be left unchanged.

Follow CAP on Social Media

Listen to the CAP Podcast

The Tesla-fication of Vaccines

175 former heads of state, Nobel Prize winners and other illustrious eminences added their support to the call for the U.S. government to mandate a relaxing of intellectual property laws to allow countries in the Global South to mass-produce vaccines without fear of being sued. One of ...

Analysis from Cobus van Staden

The Tesla-fication of Vaccines

175 former heads of state, Nobel Prize winners and other illustrious eminences added their support to the call for the U.S. government to mandate a relaxing of intellectual property laws to allow countries in the Global South to mass-produce vaccines without fear of being sued. One of the more revealing details in this discussion is that the mechanism for countries to use a health emergency to momentarily suspend intellectual property rights already exists ...

Chile’s Reliance on Chinese-Made Vaccines Provides a Cautionary Example for Public Health Officials in Africa and Other Developing Regions

A number of events have converged to further constrict the flow of COVID-19 vaccines to Africa and other regions throughout the Global South. India, once a major vaccine exporter, halted all overseas shipments in an effort to contain a massive surge of infections at ...

Concerns Over Chinese Vaccine Efficacy Have Had No Measurable Impact on Distribution

Leaders and public health officials in developing countries have seemingly brushed aside concerns about the efficacy of Chinese-made vaccines. Many are courting Chinese pharmaceutical manufacturers to secure further supplies. According to the latest figures compiled by Chinese state-run ...

Chinese Vaccine Deliveries to Africa Lag Far Behind the Rest of the World

New data about where Chinese-made COVID-19 vaccine are shipped around the world reveals that despite lots of lofty political rhetoric and media coverage, deliveries to Africa lags far behind the rest of the world. To date, just over 6 million doses ...

More Than Half a Billion Doses of Chinese Vaccines Will be Manufactured Overseas Every Year

Chinese pharmaceutical companies have finalized production licensing agreements with seven countries around the world that will enable the production of just under 600 million COVID-19 vaccine doses every year, according to data from Bridge. Bridge notes that at ...

Although Quantities Remain Low, the Pace of Chinese Vaccine Deliveries in Africa Accelerates

The confirmation from the Bridge tracking report that the overall quantity of Chinese vaccine deliveries to Africa is comparatively low provides a new perspective on the constant vaccine-related propaganda news coverage produced by China's state-owned media outlets and its official diplomatic Twitter channels across the ...

With the J&J Jab Stalled in South Africa, EFF Party Leader Julius Malema Calls on Government to Approve Chinese, Russian Vaccines

One day after the South African government suspended the rollout of the U.S.-made Johnson & Johnson COVID-19 vaccine due to worries about blood clots, opposition leader and head of the Economic Freedom Fighters party Julius Malema called on the government to grant emergency approval ...

VOA Report Criticizes Chinese Vaccines Using Many of the Same Propaganda Tactics That Chinese Used to Point Out Flaws in U.S. Jabs

There was widespread outrage in the U.S. last year when Chinese propaganda outlets and Foreign Ministry spokespeople issued false claims and sowed doubts over the safety of Pfizer vaccines. Now, it appears that the U.S. government-owned media is doing something similar, with poorly reported ...

Even After Learning Chinese Vaccines Aren’t as Effective, Developing Countries are Committed to Using Them. Here’s Why.

The low-efficacy rates of Chinese-made COVID-19 vaccines emerged as one of the main reasons cited by Beijing's critics in the U.S. and Europe as to why developing countries should think twice about procuring too many doses of Sinopharm or Sinovac jabs.

There Isn’t Much Time Left if the U.S. Wants to Challenge China on Vaccine Distribution

With U.S. vaccination rates on the rise and predictions that the country will reach herd immunity by mid-summer, confidence in Washington's pundit and political circles has been steadily rising that the United States will finally be well-positioned to challenge China's early lead ...

Belt & Road and Vaccines Emerge as New Chinese Vectors to Bend the International Order to Its Will, Warns New U.S. Intelligence Report

China's push for "global power" emerged as the top threat to the United States using initiatives including the Belt & Road Initiative and COVID-19 vaccine distribution emerged as the top threat facing the United States, according to an important annual intelligence assessment released on ...
Page 1 of 131213